A lateral flow test device for the qualitative detection of antibodies to Treponema pallidum in whole blood, serum or plasma. The result is read at 10 minutes.
The inSTIcheck™ syphilis rapid test is a rapid chromatographic immunoassay for the qualitative detection of antibody to Treponema pallidum in serum, plasma or whole blood. It is for professional in vitro diagnostic use, as an aid to diagnosis.
This is a treponemal antibody test. The insert warns that a positive result is not useful for establishing a diagnosis of syphilis, because in most situations such a result may reflect a prior treated infection. A negative result does not exclude incubating or early primary disease. A clinician must interpret every result with other clinical and laboratory findings.
First Diagnostic™ Corporation brands and distributes this test within its catalog of rapid tests.
| Brand | inSTIcheck™ |
|---|---|
| Catalog number | 85226400105 (also ATF-112) |
| Format | Lateral flow test device with sample well, test area (T) and control area (C) |
| Analyte / target | Antibodies to Treponema pallidum |
| Specimen | Whole blood, serum or plasma |
| Sample volume | 20 µl (1 drop) of serum or plasma, or 40 µl (2 drops) of whole blood, then two drops of assay buffer |
| Time to result | Read at 10 minutes |
| Read window | Do not interpret the result after more than 30 minutes |
| Kit contents | Individually pouched test devices with pipettes; 1 assay buffer bottle |
| Storage | 4–30 °C in the sealed pouch; do not freeze |
| Intended user | Healthcare professionals |
| Regulatory | Documentation available on request |
| Insert document | Package insert version V.10012008 |
The device is a membrane-based lateral flow test for antibody detection. Recombinant antigens are coated on the test area of the membrane and on colored particles.
When the specimen is applied to the sample well, it reacts with the antigen-coated colored particles. The mixture migrates toward the result window and reacts with the recombinant antigens in the test area. If the specimen contains antibodies to Treponema pallidum, a colored line appears in the test area. A colored line always appears in the control area if the test has been performed properly.
This summary does not replace the instructions for use supplied with the kit.
For confirmation, the insert calls for further analysis of the specimen, such as ELISA and/or western blot.
inSTIcheck™ Syphilis Test Device compared with a commercial EIA test (ELISA) using clinical specimens (339 results), as printed in the product insert.
| inSTIcheck™ result | ELISA positive | ELISA negative | Total |
|---|---|---|---|
| Positive | 112 | 1 | 113 |
| Negative | 1 | 225 | 226 |
| Total | 113 | 226 | 339 |
Percentages printed in the insert: relative sensitivity 99.1%, relative specificity 99.6%. Source: product insert.
The package insert supplied with the kit is the reference document for this test.
Finger stick whole blood should be tested immediately. Plasma or serum may be stored at 2–8 °C for up to 3 days, or below -20 °C for long-term storage. Whole blood collected by vein puncture into EDTA, citrate or heparin and stored at 2–8 °C should be used within three days.
Store the test device as packaged in the sealed pouch at 4–30 °C. Keep it in the pouch until use and do not freeze it.
Individually pouched test devices with pipettes and 1 assay buffer bottle. The insert does not state the pack size; confirm it on your quotation.
The package insert is listed with our other product inserts and instructions for use. Regulatory documentation is available on request.
Complete the distributor application or email sales@firstdiagnostic.com with catalog number 85226400105 and the quantity you need.
Tell us your market, the catalog number and your expected volumes. First Diagnostic supplies professional buyers outside the United States.
Source: inSTIcheck™ Syphilis Rapid Treponema pallidum Test Device package insert, product code ATF-112 or 85226400105, version V.10012008 · Last reviewed: October 2026 · First Diagnostic™ editorial team
Regulatory status: Products shown on this website are for professional in vitro diagnostic use. They are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale in the United States. Product availability and regulatory status vary by country; contact us for the status in your market.